Nida Subhani, MD
Infectious Disease · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Subhani’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C166551 · Current
Licensed to practise in California · since 2019 · expires 2027-11-30 · University of Karachi, Sind Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$99,706
Medicare paid this office $99,706 for 224 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 164 | $60,072 | $104 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 141 | $17,892 | $113 |
| Return visit (30+ min) | 32 | $9,558 | $114 |
| Short return visit (20+ min) | 54 | $7,397 | $83 |
| New patient visit (45+ min) | 16 | $2,358 | $147 |
Who their Medicare patients are
224 Original Medicare patients in 2024. Average age 75 · Under 65 11% · 85 and older 22% · Women 50% · Also on Medicaid 42% · Health risk score 3.12. Above the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Chronic kidney disease 64% · Coronary heart disease 52% · Diabetes 51% · Heart failure 42% · Atrial fibrillation 36% · Depression 36% · Dementia 30% · COPD 26% · Cancer 23% · Stroke 19%.
The office billed $400,515, Medicare allowed $127,669 and paid $99,706; for 946 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 224 | 946 | 75 | 3.12 | $400,515 | $99,706 |
| 2023 | 223 | 909 | 76 | 3.01 | $370,012 | $97,416 |
| 2022 | 238 | 967 | 75 | 2.80 | $379,392 | $92,177 |
| 2021 | 243 | 1,112 | 74 | 2.49 | $537,239 | $121,761 |
| 2020 | 218 | 966 | 75 | 2.97 | $557,173 | $115,312 |
| 2019 | 549 | 1,280 | 70 | 2.87 | $266,697 | $92,406 |
| 2018 | 614 | 1,530 | 70 | 2.74 | $291,837 | $99,545 |
| 2017 | 624 | 1,722 | 70 | 2.76 | $291,490 | $99,669 |
| 2016 | 639 | 1,820 | 71 | 2.81 | $330,697 | $121,730 |
| 2015 | 567 | 1,768 | 71 | 2.90 | $310,597 | $116,587 |
| 2014 | 497 | 1,666 | 70 | 2.66 | $270,246 | $105,531 |
| 2013 | 447 | 1,341 | 71 | 2.71 | $204,411 | $86,445 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 153 | $55,780 | $104 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 151 | $18,647 | $112 |
| Return visit (30+ min) | 39 | $11,282 | $120 |
| Short return visit (20+ min) | 49 | $6,556 | $80 |
| New patient visit (60+ min) | 16 | $3,075 | $192 |
2022: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 177 | $55,320 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 161 | $19,951 | $114 |
| Short return visit (20+ min) | 54 | $9,379 | $82 |
| Return visit (30+ min) | 13 | $2,505 | $119 |
| New patient visit (45+ min) | 13 | $1,869 | $144 |
2021: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 170 | $58,175 | $93 |
| Critical care, first 30-74 minutes | 32 | $24,899 | $195 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 159 | $20,203 | $115 |
| Short return visit (20+ min) | 41 | $9,876 | $88 |
| Return visit (30+ min) | 14 | $2,758 | $120 |
| New patient visit (45+ min) | 14 | $1,993 | $142 |
2020: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 148 | $47,119 | $96 |
| Critical care, first 30-74 minutes | 51 | $37,576 | $201 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 129 | $17,645 | $124 |
| Short return visit (20+ min) | 26 | $4,227 | $73 |
| New patient visit (45+ min) | 26 | $3,929 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,716 | $66 |
2019: 8 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 271 | $32,758 | $105 |
| Short return visit (20+ min) | 189 | $20,261 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 136 | $13,734 | $57 |
| New patient visit (45+ min) | 71 | $8,963 | $126 |
| Return visit (30+ min) | 86 | $6,804 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,314 | $156 |
| Short return visit | 35 | $1,217 | $32 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $415 | $30 |
2018: 10 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 334 | $38,966 | $100 |
| Short return visit (20+ min) | 214 | $19,915 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 166 | $14,980 | $55 |
| Return visit (30+ min) | 123 | $11,008 | $74 |
| Short return visit | 88 | $3,693 | $30 |
| New patient visit (45+ min) | 30 | $3,414 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,531 | $158 |
| New patient visit (30+ min) | 12 | $735 | $61 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $695 | $29 |
| Insertion of needle into vein for collection of blood sample | 17 | $76 | $3 |
2017: 11 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 316 | $38,157 | $97 |
| Short return visit (20+ min) | 228 | $23,754 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 136 | $10,330 | $53 |
| Return visit (30+ min) | 87 | $7,244 | $68 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 115 | $4,620 | $28 |
| Short return visit | 98 | $3,855 | $29 |
| New patient visit (30+ min) | 49 | $3,699 | $75 |
| New patient visit (45+ min) | 28 | $3,092 | $110 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 30 | $1,945 | $65 |
| X-ray of chest, 2 views, front and side | 31 | $337 | $10 |
| Insertion of needle into vein for collection of blood sample | 28 | $135 | $3 |
2016: 11 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 357 | $43,621 | $104 |
| Short return visit (20+ min) | 247 | $30,057 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 137 | $14,065 | $56 |
| New patient visit (45+ min) | 57 | $6,709 | $118 |
| Return visit (30+ min) | 68 | $5,567 | $73 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 129 | $5,395 | $31 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,751 | $158 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 45 | $3,708 | $77 |
| New patient visit (30+ min) | 44 | $3,506 | $80 |
| Short return visit | 51 | $1,887 | $31 |
| Insertion of needle into vein for collection of blood sample | 28 | $105 | $3 |
2015: 11 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 286 | $34,495 | $106 |
| Short return visit (20+ min) | 217 | $23,984 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 137 | $15,210 | $57 |
| New patient visit (45+ min) | 95 | $11,207 | $118 |
| Return visit (30+ min) | 72 | $7,828 | $70 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 161 | $7,532 | $30 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,698 | $158 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 37 | $2,963 | $78 |
| New patient visit (30+ min) | 36 | $2,663 | $74 |
| Short return visit | 53 | $1,910 | $29 |
| Insertion of needle into vein for collection of blood sample | 23 | $106 | $3 |
2014: 10 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 273 | $33,575 | $106 |
| Short return visit (20+ min) | 160 | $14,953 | $50 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 205 | $12,534 | $30 |
| Return visit (30+ min) | 84 | $11,524 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $8,319 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $6,943 | $56 |
| New patient visit (45+ min) | 53 | $6,118 | $115 |
| Short return visit | 93 | $4,133 | $32 |
| New patient visit (30+ min) | 51 | $3,797 | $74 |
| Insertion of needle into vein for collection of blood sample | 20 | $100 | $3 |
2013: 10 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 210 | $24,362 | $105 |
| Short return visit (20+ min) | 154 | $13,816 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 104 | $10,991 | $55 |
| Return visit (30+ min) | 88 | $10,588 | $70 |
| New patient visit (45+ min) | 62 | $6,913 | $111 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 137 | $6,634 | $29 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,569 | $155 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 43 | $3,344 | $76 |
| New patient visit (30+ min) | 32 | $2,403 | $75 |
| Short return visit | 40 | $1,566 | $33 |
Medicaid work
$11,318 in 2024
Medicaid paid $11,318 for 278 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 278 | $11,318 |
| 2024 | 278 | 1 | 22 | $11,318 |
| 2023 | 29 | 1 | 12 | $1,128 |
| 2022 | 116 | 1 | 16 | $3,348 |
| 2021 | 119 | 1 | 16 | $1,763 |
| 2020 | 173 | 3 | 41 | $6,292 |
| 2019 | 1,685 | 7 | 116 | $55,441 |
| 2018 | 1,782 | 8 | 118 | $62,977 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 29 | $1,128 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 116 | $3,348 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 119 | $1,763 |
2020
| Return visit (30+ min) | 47 | $2,458 |
| Short return visit (20+ min) | 81 | $2,450 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 45 | $1,383 |
2019
| Short return visit (20+ min) | 1,014 | $32,834 |
| Return visit (30+ min) | 400 | $18,330 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 24 | $1,328 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 58 | $1,321 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 105 | $1,078 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 70 | $414 |
| Radiologic examination, chest; 2 views | 14 | $136 |
2018
| Return visit (30+ min) | 640 | $34,095 |
| Short return visit (20+ min) | 834 | $25,244 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 45 | $1,326 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 135 | $1,214 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 34 | $441 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 57 | $289 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 25 | $219 |
| Short return visit | 12 | $148 |
Drugs they prescribed that Part D paid
$167,554
Pharmacies billed $167,554 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 210) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
168 generic and 42 brand-name prescriptions · $167,554 in drug cost · 107 antibiotic prescriptions to 44 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Biktarvy | 17 | $98,333 | $5,784 |
| Descovy | 12 | $28,903 | $2,409 |
| Rifampin | 12 | $419 | $35 |
| Methenamine Hippurate | 12 | $381 | $32 |
| Sulfamethoxazole-Trimethoprim | 17 | $363 | $21 |
See all 8 drugs
| Biktarvy | 17 | $98,333 | $5,784 |
| Descovy | 12 | $28,903 | $2,409 |
| Rifampin | 12 | $419 | $35 |
| Methenamine Hippurate | 12 | $381 | $32 |
| Sulfamethoxazole-Trimethoprim | 17 | $363 | $21 |
| Doxycycline Hyclate | 12 | $209 | $17 |
| Ciprofloxacin | 25 | $99 | $4 |
| Cephalexin | 11 | $54 | $5 |
Year by year
| 2024 | 210 | 59 | 0% (0) | 20% | $167,554 |
| 2023 | 145 | 47 | None | None | $67,828 |
| 2022 | 120 | 38 | 0% (0) | 13% | $43,689 |
| 2021 | 197 | 48 | None | 10% | $47,060 |
| 2020 | 532 | 63 | None | 31% | $362,395 |
| 2019 | 1,567 | 162 | 4% (64) | 24% | $1,014,647 |
| 2018 | 1,971 | 173 | 2% (40) | 24% | $1,148,837 |
| 2017 | 1,869 | 171 | 2% (44) | None | $1,333,171 |
| 2016 | 1,737 | 192 | 3% (48) | None | $2,137,898 |
| 2015 | 1,734 | 177 | 4% (62) | 23% | $1,285,520 |
| 2014 | 1,296 | 137 | 3% (32) | None | $366,848 |
| 2013 | 901 | 106 | 3% (24) | 20% | $94,913 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Vancomycin | 15 | $1,637 | $109 |
| Ethambutol | 13 | $430 | $33 |
| Rifampin | 13 | $164 | $13 |
| Azithromycin | 12 | $143 | $12 |
2022: 3 drugs
| Vancomycin | 11 | $1,854 | $169 |
| Doxycycline Hyclate | 15 | $875 | $58 |
| Ciprofloxacin | 15 | $70 | $5 |
2021: 4 drugs
| Fosfomycin Tromethamine | 21 | $6,145 | $293 |
| Doxycycline Hyclate | 37 | $3,439 | $93 |
| Vancomycin | 14 | $2,221 | $159 |
| Cefdinir | 28 | $1,963 | $70 |
2020: 13 drugs
| Genvoya | 30 | $100,105 | $3,337 |
| Atripla | 17 | $53,033 | $3,120 |
| Triumeq | 11 | $34,769 | $3,161 |
| Prezcobix | 11 | $23,369 | $2,124 |
| Truvada | 11 | $21,621 | $1,966 |
| Isentress | 11 | $19,402 | $1,764 |
| Doxycycline Hyclate | 20 | $1,165 | $58 |
| Entecavir | 20 | $745 | $37 |
| Doxycycline Monohydrate | 11 | $436 | $40 |
| Lisinopril | 18 | $122 | $7 |
| Omeprazole | 19 | $96 | $5 |
| Atorvastatin | 11 | $89 | $8 |
| Pravastatin | 16 | $66 | $4 |
2019: 51 drugs
| Epclusa | 11 | $283,743 | $25,795 |
| Atripla | 28 | $83,122 | $2,969 |
| Triumeq | 19 | $56,994 | $3,000 |
| Genvoya | 18 | $56,716 | $3,151 |
| Stribild | 13 | $45,191 | $3,476 |
| Daptomycin | 15 | $33,201 | $2,213 |
| Truvada | 12 | $22,487 | $1,874 |
| Isentress | 11 | $18,271 | $1,661 |
| Vancomycin | 55 | $13,379 | $243 |
| Ceftriaxone | 46 | $11,470 | $249 |
| Novolog Flexpen | 17 | $9,705 | $571 |
| Levemir | 14 | $8,831 | $631 |
| Advair Diskus | 13 | $5,298 | $408 |
| Itraconazole | 18 | $5,178 | $288 |
| Myrbetriq | 12 | $4,983 | $415 |
| Doxycycline Hyclate | 56 | $4,356 | $78 |
| Entecavir | 25 | $2,239 | $90 |
| Niacin Er | 12 | $1,433 | $119 |
| Ventolin Hfa | 14 | $910 | $65 |
| Hydrocodone-Acetaminophen | 39 | $610 | $16 |
| Doxycycline Monohydrate | 23 | $567 | $25 |
| Rifampin | 11 | $527 | $48 |
| Amoxicillin-Clavulanate Potass | 18 | $500 | $28 |
| Pantoprazole | 31 | $456 | $15 |
| Gabapentin | 24 | $455 | $19 |
| Levothyroxine | 33 | $423 | $13 |
| Allopurinol | 16 | $321 | $20 |
| Atorvastatin | 32 | $308 | $10 |
| Mirtazapine | 19 | $284 | $15 |
| Clindamycin | 12 | $284 | $24 |
| Carvedilol | 39 | $267 | $7 |
| Lorazepam | 15 | $213 | $14 |
| Flurbiprofen | 11 | $203 | $18 |
| Furosemide | 28 | $181 | $6 |
| Fluoxetine | 17 | $166 | $10 |
| Omeprazole | 36 | $160 | $4 |
| Metoprolol | 16 | $158 | $10 |
| Alprazolam | 16 | $115 | $7 |
| Glipizide Er | 12 | $113 | $9 |
| Fluticasone Propionate | 20 | $110 | $6 |
| Propranolol | 12 | $88 | $7 |
| Lisinopril | 32 | $86 | $3 |
| Sulfamethoxazole-Trimethoprim | 13 | $82 | $6 |
| Pravastatin | 22 | $79 | $4 |
| Amlodipine Besylate | 14 | $73 | $5 |
| Simvastatin | 12 | $62 | $5 |
| Hydrochlorothiazide | 18 | $53 | $3 |
| Tramadol | 15 | $42 | $3 |
| Meloxicam | 11 | $39 | $4 |
| Montelukast | 13 | $36 | $3 |
| Atenolol | 11 | $10 | $1 |
2018: 72 drugs
| Harvoni | 13 | $413,895 | $31,838 |
| Atripla | 22 | $62,037 | $2,820 |
| Daptomycin | 20 | $58,410 | $2,920 |
| Triumeq | 20 | $58,208 | $2,910 |
| Truvada | 31 | $54,603 | $1,761 |
| Genvoya | 13 | $39,000 | $3,000 |
| Tivicay | 18 | $32,265 | $1,792 |
| Isentress | 13 | $20,414 | $1,570 |
| Atazanavir Sulfate | 13 | $11,526 | $887 |
| Levemir | 15 | $8,469 | $565 |
| Novolog Flexpen | 14 | $7,772 | $555 |
| Vancomycin | 36 | $6,979 | $194 |
| Victoza 2-Pak | 11 | $6,305 | $573 |
| Sevelamer Carbonate | 11 | $6,081 | $553 |
| Advair Diskus | 12 | $4,850 | $404 |
| Ceftriaxone | 39 | $4,796 | $123 |
| Xarelto | 11 | $4,691 | $426 |
| Piperacillin-Tazobactam | 17 | $4,373 | $257 |
| Itraconazole | 13 | $3,478 | $268 |
| Doxycycline Hyclate | 61 | $2,497 | $41 |
| Entecavir | 12 | $1,888 | $157 |
| Ventolin Hfa | 19 | $1,366 | $72 |
| Omega-3 Acid Ethyl Esters | 14 | $1,181 | $84 |
| Ethambutol | 19 | $968 | $51 |
| Rifampin | 17 | $844 | $50 |
| Mirtazapine | 29 | $797 | $27 |
| Doxycycline Monohydrate | 29 | $789 | $27 |
| Levothyroxine | 47 | $779 | $17 |
| Niacin Er | 12 | $772 | $64 |
| Amoxicillin-Clavulanate Potass | 22 | $717 | $33 |
| Bupropion Hcl Sr | 13 | $601 | $46 |
| Allopurinol | 31 | $580 | $19 |
| Pantoprazole | 47 | $562 | $12 |
| Gabapentin | 53 | $480 | $9 |
| Latanoprost | 11 | $438 | $40 |
| Azithromycin | 20 | $417 | $21 |
| Hydrocodone-Acetaminophen | 32 | $404 | $13 |
| Fenofibrate | 12 | $395 | $33 |
| Atorvastatin | 30 | $372 | $12 |
| Oxybutynin Chloride Er | 13 | $366 | $28 |
| Fludrocortisone Acetate | 14 | $339 | $24 |
| Finasteride | 12 | $324 | $27 |
| Levofloxacin | 19 | $299 | $16 |
| Potassium Chloride | 20 | $297 | $15 |
| Carvedilol | 56 | $268 | $5 |
| Furosemide | 58 | $244 | $4 |
| Isosorbide Mononitrate Er | 18 | $241 | $13 |
| Clindamycin | 19 | $237 | $12 |
| Alprazolam | 27 | $226 | $8 |
| Citalopram Hbr | 36 | $211 | $6 |
| Glipizide Er | 22 | $197 | $9 |
| Insulin | 11 | $193 | $18 |
| Omeprazole | 29 | $189 | $7 |
| Pravastatin | 17 | $182 | $11 |
| Tamsulosin | 13 | $176 | $14 |
| Nystatin | 12 | $170 | $14 |
| Metoprolol | 16 | $155 | $10 |
| Clopidogrel | 22 | $151 | $7 |
| Ciprofloxacin | 13 | $135 | $10 |
| Sulfamethoxazole-Trimethoprim | 27 | $134 | $5 |
| Amoxicillin | 16 | $129 | $8 |
| Losartan | 14 | $123 | $9 |
| Lorazepam | 21 | $98 | $5 |
| Mupirocin | 11 | $93 | $8 |
| Clonidine | 12 | $75 | $6 |
| Fluticasone Propionate | 13 | $75 | $6 |
| Montelukast | 12 | $64 | $5 |
| Simvastatin | 12 | $61 | $5 |
| Lisinopril | 19 | $54 | $3 |
| Propranolol | 12 | $46 | $4 |
| Prednisone | 11 | $46 | $4 |
| Dicyclomine | 12 | $45 | $4 |
2017: 69 drugs
| Harvoni | 11 | $358,485 | $32,590 |
| Zepatier | 17 | $314,711 | $18,512 |
| Triumeq | 22 | $58,247 | $2,648 |
| Atripla | 19 | $49,928 | $2,628 |
| Complera | 14 | $39,111 | $2,794 |
| Truvada | 19 | $31,230 | $1,644 |
| Reyataz | 15 | $22,196 | $1,480 |
| Vancomycin | 93 | $16,288 | $175 |
| Invanz | 22 | $14,011 | $637 |
| Lantus | 11 | $8,513 | $774 |
| Novolog Flexpen | 13 | $7,040 | $542 |
| Victoza 2-Pak | 11 | $5,890 | $535 |
| Ceftriaxone | 39 | $5,778 | $148 |
| Advair Diskus | 13 | $4,764 | $366 |
| Itraconazole | 11 | $4,299 | $391 |
| Doxycycline Hyclate | 78 | $3,999 | $51 |
| Norvir | 11 | $3,665 | $333 |
| Cefepime | 21 | $3,367 | $160 |
| Omega-3 Acid Ethyl Esters | 12 | $1,852 | $154 |
| Piperacillin-Tazobactam | 13 | $1,473 | $113 |
| Ventolin Hfa | 18 | $1,415 | $79 |
| Proair Hfa | 16 | $1,337 | $84 |
| Cefuroxime | 19 | $1,196 | $63 |
| Hydroxychloroquine Sulfate | 12 | $1,028 | $86 |
| Fenofibrate | 13 | $910 | $70 |
| Oxycodone-Acetaminophen | 13 | $800 | $62 |
| Doxycycline Monohydrate | 33 | $731 | $22 |
| Oxybutynin Chloride Er | 18 | $682 | $38 |
| Levothyroxine | 45 | $581 | $13 |
| Bupropion Hcl Sr | 13 | $573 | $44 |
| Amitriptyline | 18 | $484 | $27 |
| Levofloxacin | 41 | $479 | $12 |
| Gabapentin | 45 | $474 | $11 |
| Nitrofurantoin Mono-Macro | 12 | $460 | $38 |
| Atorvastatin | 34 | $396 | $12 |
| Fenofibrate | 13 | $383 | $29 |
| Citalopram Hbr | 28 | $277 | $10 |
| Amoxicillin-Clavulanate Potass | 20 | $271 | $14 |
| Carvedilol | 61 | $265 | $4 |
| Potassium Chloride | 18 | $263 | $15 |
| Klor-Con M20 | 11 | $255 | $23 |
| Isosorbide Mononitrate Er | 25 | $239 | $10 |
| Fludrocortisone Acetate | 13 | $224 | $17 |
| Mirtazapine | 22 | $212 | $10 |
| Metoprolol | 17 | $203 | $12 |
| Hydrocodone-Acetaminophen | 21 | $192 | $9 |
| Pravastatin | 18 | $174 | $10 |
| Alprazolam | 28 | $172 | $6 |
| Nifedipine Er | 12 | $167 | $14 |
| Furosemide | 40 | $158 | $4 |
| Pantoprazole | 14 | $155 | $11 |
| Fluticasone Propionate | 11 | $144 | $13 |
| Glipizide Er | 17 | $140 | $8 |
| Clopidogrel | 23 | $137 | $6 |
| Omeprazole | 22 | $130 | $6 |
| Lisinopril | 33 | $114 | $3 |
| Fluoxetine | 11 | $100 | $9 |
| Ciprofloxacin | 14 | $99 | $7 |
| Montelukast | 12 | $89 | $7 |
| Lorazepam | 18 | $89 | $5 |
| Warfarin | 11 | $88 | $8 |
| Simvastatin | 19 | $71 | $4 |
| Losartan | 12 | $66 | $6 |
| Amlodipine Besylate | 17 | $66 | $4 |
| Amoxicillin | 12 | $62 | $5 |
| Diazepam | 11 | $62 | $6 |
| Metoprolol | 20 | $61 | $3 |
| Sulfamethoxazole-Trimethoprim | 15 | $52 | $3 |
| Prednisone | 12 | $40 | $3 |
2016: 63 drugs
| Harvoni | 23 | $720,165 | $31,312 |
| Sovaldi | 18 | $504,637 | $28,035 |
| Daklinza | 13 | $272,907 | $20,993 |
| Atripla | 22 | $53,353 | $2,425 |
| Triumeq | 14 | $34,516 | $2,465 |
| Complera | 11 | $27,024 | $2,457 |
| Invanz | 26 | $20,579 | $791 |
| Prezista | 14 | $19,135 | $1,367 |
| Vancomycin | 53 | $12,515 | $236 |
| Lantus | 19 | $10,453 | $550 |
| Victoza 2-Pak | 11 | $5,394 | $490 |
| Tradjenta | 12 | $4,322 | $360 |
| Ceftriaxone | 33 | $4,282 | $130 |
| Sodium Chloride | 15 | $3,996 | $266 |
| Symbicort | 12 | $3,535 | $295 |
| Doxycycline Hyclate | 51 | $2,845 | $56 |
| Ribavirin | 15 | $2,131 | $142 |
| Duloxetine | 11 | $1,482 | $135 |
| Gabapentin | 56 | $1,105 | $20 |
| Hydroxychloroquine Sulfate | 12 | $1,092 | $91 |
| Dapsone | 12 | $844 | $70 |
| Fenofibrate | 13 | $785 | $60 |
| Zaleplon | 11 | $688 | $63 |
| Levofloxacin | 34 | $657 | $19 |
| Divalproex Sodium Er | 12 | $608 | $51 |
| Levothyroxine | 46 | $588 | $13 |
| Midodrine | 11 | $509 | $46 |
| Fenofibrate | 16 | $483 | $30 |
| Doxycycline Monohydrate | 24 | $465 | $19 |
| Atorvastatin | 26 | $422 | $16 |
| Metoprolol | 21 | $385 | $18 |
| Ciprofloxacin | 38 | $369 | $10 |
| Amitriptyline | 19 | $367 | $19 |
| Fludrocortisone Acetate | 13 | $338 | $26 |
| Doxazosin Mesylate | 16 | $326 | $20 |
| Hydrocodone-Acetaminophen | 15 | $313 | $21 |
| Cephalexin | 32 | $297 | $9 |
| Carvedilol | 43 | $288 | $7 |
| Warfarin | 23 | $266 | $12 |
| Azithromycin | 13 | $199 | $15 |
| Clindamycin | 13 | $198 | $15 |
| Alprazolam | 27 | $153 | $6 |
| Lorazepam | 22 | $151 | $7 |
| Nifedipine Er | 11 | $150 | $14 |
| Clopidogrel | 17 | $148 | $9 |
| Isosorbide Mononitrate Er | 12 | $145 | $12 |
| Pravastatin | 13 | $143 | $11 |
| Buspirone | 15 | $127 | $8 |
| Hydralazine | 15 | $121 | $8 |
| Glyburide | 15 | $119 | $8 |
| Citalopram Hbr | 23 | $112 | $5 |
| Simvastatin | 24 | $110 | $5 |
| Lisinopril | 26 | $108 | $4 |
| Escitalopram | 14 | $102 | $7 |
| Amlodipine Besylate | 23 | $91 | $4 |
| Metoprolol | 17 | $80 | $5 |
| Gemfibrozil | 12 | $70 | $6 |
| Losartan | 13 | $64 | $5 |
| Tramadol | 24 | $59 | $2 |
| Dicyclomine | 12 | $59 | $5 |
| Hydrochlorothiazide | 15 | $56 | $4 |
| Furosemide | 13 | $51 | $4 |
| Glipizide | 12 | $27 | $2 |
2015: 55 drugs
| Harvoni | 25 | $799,704 | $31,988 |
| Atripla | 19 | $42,240 | $2,223 |
| Complera | 14 | $31,628 | $2,259 |
| Prezista | 22 | $27,511 | $1,250 |
| Truvada | 12 | $16,029 | $1,336 |
| Vancomycin | 56 | $13,299 | $237 |
| Invanz | 24 | $13,278 | $553 |
| Norvir | 21 | $7,962 | $379 |
| Doxycycline Hyclate | 68 | $6,317 | $93 |
| Lantus | 13 | $4,841 | $372 |
| Tradjenta | 12 | $4,076 | $340 |
| Ceftriaxone | 34 | $2,758 | $81 |
| Duloxetine | 13 | $1,533 | $118 |
| Gabapentin | 47 | $1,133 | $24 |
| Levofloxacin | 44 | $1,092 | $25 |
| Fluconazole | 21 | $794 | $38 |
| Zaleplon | 11 | $656 | $60 |
| Levothyroxine | 37 | $589 | $16 |
| Hydrocodone-Acetaminophen | 28 | $561 | $20 |
| Fludrocortisone Acetate | 16 | $470 | $29 |
| Doxazosin Mesylate | 17 | $427 | $25 |
| Fluticasone Propionate | 14 | $380 | $27 |
| Sulfamethoxazole-Trimethoprim | 23 | $362 | $16 |
| Cephalexin | 30 | $324 | $11 |
| Doxycycline Monohydrate | 14 | $279 | $20 |
| Oxybutynin Chloride | 12 | $277 | $23 |
| Ciprofloxacin | 32 | $248 | $8 |
| Warfarin | 17 | $232 | $14 |
| Carvedilol | 44 | $212 | $5 |
| Metronidazole | 13 | $209 | $16 |
| Amitriptyline | 16 | $199 | $12 |
| Alprazolam | 25 | $171 | $7 |
| Klor-Con M20 | 13 | $166 | $13 |
| Sodium Chloride | 11 | $164 | $15 |
| Nifedipine Er | 12 | $163 | $14 |
| Losartan | 28 | $154 | $6 |
| Metformin | 12 | $154 | $13 |
| Amlodipine Besylate | 41 | $153 | $4 |
| Lisinopril | 37 | $141 | $4 |
| Clopidogrel | 17 | $138 | $8 |
| Pantoprazole | 11 | $129 | $12 |
| Buspirone | 11 | $127 | $12 |
| Furosemide | 46 | $127 | $3 |
| Hydrochlorothiazide | 27 | $122 | $5 |
| Metoprolol | 24 | $121 | $5 |
| Simvastatin | 27 | $120 | $4 |
| Pramipexole Dihydrochloride | 12 | $115 | $10 |
| Potassium Chloride | 14 | $111 | $8 |
| Tramadol | 25 | $102 | $4 |
| Lorazepam | 14 | $99 | $7 |
| Isosorbide Mononitrate Er | 12 | $98 | $8 |
| Glyburide | 18 | $87 | $5 |
| Citalopram Hbr | 26 | $81 | $3 |
| Gemfibrozil | 13 | $71 | $5 |
| Omeprazole | 11 | $70 | $6 |
2014: 45 drugs
| Atripla | 12 | $25,129 | $2,094 |
| Truvada | 12 | $15,202 | $1,267 |
| Prezista | 12 | $13,814 | $1,151 |
| Invanz | 25 | $13,186 | $527 |
| Doxycycline Hyclate | 65 | $8,400 | $129 |
| Spiriva | 11 | $3,109 | $283 |
| Norvir | 12 | $3,056 | $255 |
| Duloxetine | 16 | $2,796 | $175 |
| Cefepime | 12 | $2,021 | $168 |
| Fluconazole | 46 | $1,940 | $42 |
| Vancomycin | 31 | $1,777 | $57 |
| Ceftriaxone | 27 | $1,680 | $62 |
| Clopidogrel | 20 | $1,147 | $57 |
| Levofloxacin | 34 | $673 | $20 |
| Azithromycin | 12 | $656 | $55 |
| Doxazosin Mesylate | 16 | $605 | $38 |
| Carvedilol | 48 | $424 | $9 |
| Metronidazole | 12 | $420 | $35 |
| Sodium Chloride | 36 | $356 | $10 |
| Warfarin | 19 | $321 | $17 |
| Hydrocodone-Acetaminophen | 17 | $308 | $18 |
| Cephalexin | 25 | $283 | $11 |
| Amlodipine Besylate | 42 | $278 | $7 |
| Losartan | 38 | $276 | $7 |
| Klor-Con M20 | 12 | $220 | $18 |
| Lisinopril | 24 | $159 | $7 |
| Omeprazole | 11 | $155 | $14 |
| Nifedipine Er | 11 | $150 | $14 |
| Allopurinol | 14 | $141 | $10 |
| Furosemide | 47 | $139 | $3 |
| Alendronate | 12 | $139 | $12 |
| Sulfamethoxazole-Trimethoprim | 21 | $137 | $7 |
| Gemfibrozil | 11 | $137 | $12 |
| Glyburide | 12 | $128 | $11 |
| Hydrochlorothiazide | 33 | $126 | $4 |
| Pramipexole Dihydrochloride | 12 | $123 | $10 |
| Clonidine | 11 | $121 | $11 |
| Simvastatin | 19 | $109 | $6 |
| Mupirocin | 13 | $106 | $8 |
| Amoxicillin | 13 | $92 | $7 |
| Gabapentin | 16 | $87 | $5 |
| Levothyroxine | 15 | $85 | $6 |
| Metoprolol | 15 | $78 | $5 |
| Tramadol | 13 | $68 | $5 |
| Zolpidem | 11 | $49 | $4 |
2013: 33 drugs
| Atripla | 11 | $21,379 | $1,944 |
| Vancomycin | 24 | $11,379 | $474 |
| Doxycycline Hyclate | 46 | $4,465 | $97 |
| Invanz | 11 | $3,649 | $332 |
| Advair Diskus | 11 | $3,056 | $278 |
| Diovan | 12 | $1,881 | $157 |
| Fenofibrate | 16 | $1,051 | $66 |
| Clopidogrel | 21 | $1,018 | $48 |
| Sodium Chloride | 20 | $901 | $45 |
| Lovaza | 13 | $745 | $57 |
| Levofloxacin | 34 | $458 | $13 |
| Oxcarbazepine | 12 | $413 | $34 |
| Fluconazole | 27 | $383 | $14 |
| Doxazosin Mesylate | 16 | $306 | $19 |
| Amlodipine Besylate | 34 | $292 | $9 |
| Ranitidine | 16 | $278 | $17 |
| Carvedilol | 32 | $263 | $8 |
| Simvastatin | 25 | $218 | $9 |
| Theophylline Anhydrous | 12 | $206 | $17 |
| Pramipexole Dihydrochloride | 12 | $188 | $16 |
| Cephalexin | 24 | $185 | $8 |
| Losartan | 16 | $156 | $10 |
| Nifedipine Er | 11 | $152 | $14 |
| Glyburide | 12 | $135 | $11 |
| Furosemide | 29 | $133 | $5 |
| Triamterene-Hctz | 11 | $132 | $12 |
| Metformin | 11 | $115 | $10 |
| Lisinopril | 18 | $113 | $6 |
| Gabapentin | 14 | $96 | $7 |
| Clonidine | 12 | $91 | $8 |
| Tramadol | 11 | $56 | $5 |
| Metoprolol | 11 | $47 | $4 |
| Hydrochlorothiazide | 21 | $30 | $1 |
Professional record
- NPI
- 1770747784
- Licence
- CA C166551California C166551: Current · expires 2027-11-30
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X); Internal medicine (207R00000X)
- Mailing address
- 5575 W Las Positas Blvd Ste 210, Pleasanton, CA, 94588
- NPI first listed
- 2008-07-18
- NPI last updated
- 2024-04-17
- NPI record certified
- 2024-04-17
This is when the NPI record was last certified, not a medical board exam.